Related Experiment Video
Updated: May 25, 2026

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
[Modulation of activated oncogene c-kit expression with RNA-interference]
Abstract:
Hyperexpression of oncogene c-kit is found in 80% patients with acute myeloid leukemia (AML). The transgenic model cell line expressing the oncogene c-kit was obtained by transduction with recombinant retrovirus. We have designed small interfering RNAs (siRNA) efficiently suppressing the expression of activated oncogene c-kit. Further small hairpin RNAs (shRNA) targeting c-kit mRNA were designed and expressed in lentiviral vectors. We report a stable reduction in c-kit expression following the introduction of shRNAs into model cells as well as Kasumi-1 cells from the patient with AML.
Insights
Small hairpin RNAs (shRNA) effectively reduce oncogene c-kit expression in acute myeloid leukemia (AML) cells. This study demonstrates a novel therapeutic strategy targeting c-kit in AML patients.
Area of Science:
- Molecular Biology
- Oncology
- Gene Therapy
More Related Videos
Related Concept Videos
Experimental RNAi
Induced Pluripotent Stem Cells
Somatic cells are...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades

